Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
LLY
MRK
Add up to 3 more stocks
LLY
Eli Lilly and Company
-0.69%
$1,115.25-7.75Delayed quote: Sep 11, 2026, 3:59 PM EDT
Market Cap
$1.05T
52W Range
$712.05 - $1,292.65
MRK
Merck & Co., Inc.
-0.54%
$143.94-0.78Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$355.49B
52W Range
$77.58 - $156.92
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 37.42 | 115.15 |
| Forward P/E | 30.64 | 52.41 |
| P/B Ratio | 31.00 | 8.48 |
| P/S Ratio | 13.18 | 5.35 |
| P/FCF Ratio | 52.37 | 22.13 |
| EV/EBITDA | 29.91 | 22.76 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 84.0% | 75.4% |
| Operating Margin | 43.9% | 36.2% |
| Net Margin | 33.5% | 4.8% |
| ROE | 78.8% | 7.6% |
| ROA | 18.8% | 2.4% |
| ROIC | 27.4% | 5.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.35 | 1.32 |
| Quick Ratio | 1.00 | 1.10 |
| Debt/Equity | 1.62 | 1.29 |
| Interest Coverage | 37.34 | 17.31 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 0.6% | 2.3% |
| Payout Ratio | 22.4% | 268.8% |
| Yrs of Dividend Growth | 11 | 15 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.